An established multilingual senior executive with over 25 years of demonstrated success in regulatory, clinical development and accelerating access. Raj Long has notable experience as a senior international regulatory executive in the pharmaceutical industry, combined with strategic experience as an expert advisor to the UK Department of Health & Social Care, European Union (ECAS expert), Gates Foundation and World Health Organisation (WHO). Raj is currently a Deputy Director for safety surveillance at the Gates Foundation and supports the WHO COVID-19 vaccine manufacturing taskforce as a co-lead for regulatory.. Prior to that, Raj was Consultant Advisor to the Chief Scientist of the WHO, as well as being a WHO co-lead on the COVAX Task Force on COVID-19 vaccine manufacturing, Vice Chair of the World Dementia Council and has provided advice to numerous expert groups and government initiatives such as the G7 Global Action Against Dementia initiative and the Accelerated Access Review with NHS England. In her executive career. Raj held very senior international regulatory roles with responsibility for licensing innovative medicines in global pharmaceutical companies such as Bristol Myers Squibb, Novartis and GE Healthcare. As a recognition of Raj’s significant contributions TOPRA (Organisation for Regulatory Professionals) awarded Raj with the Lifetime Achievement Award in 2020. Additionally, in 2021 the UK Government appointed Raj to the Medicines and Healthcare products Regulatory Agency Board (MHRA) as a Non-Executive Director further consolidating her unique blend of private/public health expertise. In April 2022, Raj was also appointed as an associate member of the to the newly formed UK Health Security Agency Board (UKHSA) in 2022.